v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2023 $ 76 $ 901,471 $ 92 $ (676,421) $ 225,218
Balance at beginning (in shares) at Dec. 31, 2023 75,979,495        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities     (142)   (142)
Exercise of stock options   280     280
Exercise of stock options (in shares) 47,293        
Issuance of common shares upon RSU vesting (in shares) 360,373        
Exercise of pre-funded and common warrants $ 4 6,102     6,106
Exercise of pre-funded and common warrants (in shares) 3,357,493        
Equity-based compensation expense   8,164     8,164
Net Income (Loss)       (56,853) (56,853)
Balance at end at Mar. 31, 2024 $ 80 916,017 (50) (733,274) 182,773
Balance at end (in shares) at Mar. 31, 2024 79,744,654        
Balance at beginning at Dec. 31, 2023 $ 76 901,471 92 (676,421) 225,218
Balance at beginning (in shares) at Dec. 31, 2023 75,979,495        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities         (146)
Net Income (Loss)         (115,361)
Balance at end at Jun. 30, 2024 $ 80 925,376 (54) (791,782) 133,620
Balance at end (in shares) at Jun. 30, 2024 79,992,068        
Balance at beginning at Mar. 31, 2024 $ 80 916,017 (50) (733,274) 182,773
Balance at beginning (in shares) at Mar. 31, 2024 79,744,654        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities     (4)   (4)
Exercise of stock options   47     47
Exercise of stock options (in shares) 6,617        
Issuance of common shares upon RSU vesting (in shares) 240,797        
Equity-based compensation expense   9,312     9,312
Net Income (Loss)       (58,508) (58,508)
Balance at end at Jun. 30, 2024 $ 80 925,376 (54) (791,782) 133,620
Balance at end (in shares) at Jun. 30, 2024 79,992,068        
Balance at beginning at Dec. 31, 2024 $ 94 1,291,095 160 (922,715) 368,634
Balance at beginning (in shares) at Dec. 31, 2024 93,823,678        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities     (31)   (31)
Exercise of stock options   5,038     5,038
Exercise of stock options (in shares) 375,939        
Issuance of common shares upon RSU vesting $ 1 (1)      
Issuance of common shares upon RSU vesting (in shares) 673,790        
Equity-based compensation expense   13,413     13,413
Other   2     2
Net Income (Loss)       (74,723) (74,723)
Balance at end at Mar. 31, 2025 $ 95 1,309,547 129 (997,438) 312,333
Balance at end (in shares) at Mar. 31, 2025 94,873,407        
Balance at beginning at Dec. 31, 2024 $ 94 1,291,095 160 (922,715) 368,634
Balance at beginning (in shares) at Dec. 31, 2024 93,823,678        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities         (102)
Net Income (Loss)         (184,754)
Balance at end at Jun. 30, 2025 $ 96 1,340,608 58 (1,107,469) 233,293
Balance at end (in shares) at Jun. 30, 2025 95,999,608        
Balance at beginning at Mar. 31, 2025 $ 95 1,309,547 129 (997,438) 312,333
Balance at beginning (in shares) at Mar. 31, 2025 94,873,407        
Increase (decrease) in Stockholders' Equity          
Unrealized loss on marketable securities     (71)   (71)
Exercise of stock options   3,262     3,262
Exercise of stock options (in shares) 275,874        
Issuance of common shares upon RSU vesting (in shares) 392,283        
Exercise of pre-funded and common warrants $ 1 3,366     3,367
Exercise of pre-funded and common warrants (in shares) 458,044        
Equity-based compensation expense   24,433     24,433
Net Income (Loss)       (110,031) (110,031)
Balance at end at Jun. 30, 2025 $ 96 $ 1,340,608 $ 58 $ (1,107,469) $ 233,293
Balance at end (in shares) at Jun. 30, 2025 95,999,608